Our mission is to digitize, decode, and decipher human biology for the prevention, early diagnosis, and treatment of chronic diseases and cancer.
in the Noise
The proprietary combination of Viome’s metatranscriptomic sequencing technology, our systems biology approach, and our AI machine learning platform is revolutionizing the health and wellness industry and transforming the potential for early diagnostics and targeted therapeutics.
Our Science & Unique Approach to Human Health
Evidence-based precision nutrition improves clinical outcomes by analyzing human and microbial molecular data with artificial intelligence.
Our AI Platform
Microbial and human gene expression are redefining how biological activities are viewed in relation to human health.
What is mRNA?
Messenger RNA, or mRNA, plays a fundamental role in human biology referring the instructions stored in DNA to make the proteins required in every living cell. Our approach is to use mRNA medicines to instruct a patient’s own cells to produce proteins that could prevent, treat, or cure disease.
Insight to Intervention
Our mRNA platform for Wellness, Diagnostics, and Therapeutics allows us to translate information into valuable insights and meaningful interventions.
Our direct-to-consumer service analyzes gene expressions (mRNA) in order to provide individuals with health insights and precision nutrition to live a healthier life.
This platform of over 400,000 samples enables us to enhance our understanding of human biology as a system in order to develop predictive biomarkers, precision diagnostics, and precision therapeutics to prevent and intercept chronic diseases.
Our predictive biomarkers provide us with the hypothesis to do clinical research and identify the signatures of chronic disease, cancers and aging.
The signatures found through diagnostics allow us to determine the mechanism of actions to develop precision therapeutics in the form of drugs, vaccines and treatments.
Viome can determine drug effectivess, including immunotherapy, which is dependent upon the human microbiome.
Our Approach to Cancer Diagnostics
Viome is committed to identifying the molecular determinants of cancer by systematically evaluating the host and/or microbial activities involved in disease onset and progression.
Carefully define the disease and non-disease cohorts based on all available clinical meta-data.
Systematically analyze those cohorts to identify a molecular signature, typically consisting of both human and microbial molecular features, that distinguishes the disease cohort from the non-disease cohort.
Validate the discovered molecular signature using an unseen independent cohort that includes clinically adjudicated meta-data.
Oral & Throat
Our CancerDetect™- Oral & Throat test was developed over multiple years by Viome Life Sciences, Inc, based on clinical studies for diagnostic development and validation. This test is a non-invasive, at-home test that detects a molecular signature associated with Oral and/or Throat cancers with high accuracy.
Viome’s commercially available CancerDetect Oral and Throat cancer test is a laboratory-developed test (LDT). This test was clinically validated with an independent cohort, with a specificity of at least 95% and a sensitivity of at least 90% for both Oral Squamous Cell Carcinoma (OSCC) and Oropharyngeal Squamous Cell Carcinoma (OPSCC). This surpasses the current standard of care - the visual and tactile exam.
“Early detection of Oral and Throat cancer saves lives. With Viome’s simple non-invasive at-home test, you can have peace of mind. And we will continuously improve this test so you can get the best technology available in the market!”
Founding CTO & Head of Discovery AI,
Viome Life Sciences
VIOME STUDY INITIATIVES
In addition to head and neck cancers, Viome has an extensive ongoing clinical study pipeline in gastrointestinal cancers including colorectal cancer, pancreatic, ovarian, cervical, and biliary cancers. We currently have cancer research trials that use saliva, blood, stool, and tumor biopsies to understand the onset and progression of cancer. By identifying the biomarkers that lead to the development of cancers, Viome can optimize early detection and identify the right therapeutic targets.
The salivary host/microbe metatranscriptomes as an accurate diagnostic indicator of oral cancer
NPJ Genomic Medicine
Our collective makes us stronger. We couldn’t do what we do without great partners. Together, we’re making a difference – join our mission.
We founded Viome Life Sciences with one goal in mind: to tackle the epidemic of chronic diseases, cancer, and aging and empower people with the information they need to live a disease-free life.
What kind of cancer does this test detect?
CancerDetect™ Oral & Throat detects the molecular features associated with oral cavity cancer (Oral Squamous Cell Carcinoma or OSCC) and/or throat cancer (oropharyngeal squamous cell carcinoma or OPSCC).
How accurate are these results?
Sensitivity: 90% for both oral & throat cancer
Sensitivity refers to a test's ability to designate an individual with a disease as positive. A highly sensitive test means that there are few false-negative results, and thus fewer cases of the disease are missed.
Specificity: 95% for both oral & throat cancer
Specificity refers to a test’s ability to designate an individual who does not have a disease as negative. A highly specific test means that there are few false-positive results, and thus few false alarms.
What should I expect if I take the test and my result is detected?
A healthcare provider licensed in your state will review your result, and provide a consultation over the phone to discuss the test result, provide educational information, and talk about your next steps. However, no medical advice, treatment, or prescriptions will be provided.
If the test is not detected, could I have another type of cancer?
CancerDetect does not detect molecular features associated with other types of cancer other than oral & throat cancers. Please discuss with your doctor about your symptoms and concerns.
What do these results mean to my health?
A result of "DETECTED" is not a diagnosis of cancer. The results of the CancerDetect test must be confirmed by diagnostic evaluation suggested by qualified health care professionals in accordance with standard medical practice. These results should be interpreted in the context of the individual's clinical risk factors. Diagnostic decisions are the responsibility of the treating physician.
A result of "NOT DETECTED" does not eliminate the possibility that a cancer is present or will occur in the future. Individuals who receive a "NOT DETECTED" result should continue with all recommended cancer screening options at intervals appropriate for the individual. The use of the CancerDetect test should not replace, supersede, or otherwise alter the use or frequency of standard of care cancer screening or detection modalities.
False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur.
What do I need to complete this test?
You will need to submit a saliva sample of good quality, create a Viome account, register your test kit and complete the questionnaires in your online account.
We will not be able to process your sample if you do not register your test kit.
We will not be able to finalize your test result if you do not complete all required questionnaires.
Work With Us
Our Grants Program
The mission of the VLS Grants Program is to enable clinicians and scientists worldwide to translate research into commercial products with clinical utility: devising new therapies and developing more accurate diagnostics and companion diagnostics.
Viome Publication Dataset Access Program
Viome is committed to supporting scientific research by enabling access to data we have included in our publications. We provide access to full summary statistics through a Data Transfer Agreement that protects the privacy of our participant's data.
Join Our Team
Our team is dedicated to making the advancements in science, technology, and medicine accessible and more readily available to consumers, helping to create a disease free world where people can take control of their own health from the comfort of their own home.